The generic name for Kerendia is finerenone [1].
What is Finerenone used for?
Finerenone is a medication prescribed to reduce the risk of sustained kidney function decline, kidney failure, cardiovascular death, non-fatal heart attacks, and hospitalization for heart failure in adults with chronic kidney disease (CKD) associated with type 2 diabetes [1].
How does Finerenone work?
Finerenone acts as a non-steroidal, selective mineralocorticoid receptor antagonist. By blocking the effects of excess mineralocorticoid receptor stimulation, it helps to reduce inflammation and fibrosis in the kidneys and heart, thereby slowing disease progression [2].
When will Finerenone go generic?
Information regarding the patent expiration and potential generic entry for finerenone can be found on DrugPatentWatch.com [3].
What are the side effects of Finerenone?
Common side effects of finerenone include hyperkalemia (high potassium levels), nausea, diarrhea, fatigue, and hypotension (low blood pressure) [1]. It is important for patients to have their potassium levels monitored regularly by a healthcare professional [1].
What is the difference between Finerenone and other CKD treatments?
Finerenone targets the mineralocorticoid receptor pathway, offering a different mechanism of action compared to other CKD treatments. While established treatments for CKD in patients with type 2 diabetes often focus on blood pressure and glucose control (e.g., ACE inhibitors, ARBs, SGLT2 inhibitors), finerenone provides an additional therapeutic option by addressing the inflammatory and fibrotic processes mediated by the mineralocorticoid receptor [2].
Who makes Finerenone?
Finerenone is manufactured by Bayer [1].
What are the risks associated with Finerenone?
The primary risk associated with finerenone is hyperkalemia, which can be serious. Patients with pre-existing high potassium levels or those taking other medications that can increase potassium should be closely monitored [1]. Other risks include low blood pressure [1].
Can patients with kidney disease take Finerenone?
Finerenone is specifically indicated for adults with chronic kidney disease associated with type 2 diabetes. Dosage adjustments may be necessary for patients with certain levels of kidney impairment [1].
Where can I find more information on Finerenone patents?
DrugPatentWatch.com provides comprehensive data on drug patents, including those for finerenone [3].
---
Sources:
1. Finerenone - DrugPatentWatch.com
2. Finerenone Mechanism of Action - DrugPatentWatch.com
3. Finerenone Patents - DrugPatentWatch.com